Sigma Capital Group
VC Fund
Edinburgh, United Kingdom
Sigma Capital Group is a VC fund in Edinburgh focused on Software and Blockchain. Sigma Capital Group plc is an AIM listed UK based specialist asset management group whose principal business is carried out through two subsidiaries investing in companies developing technologies relating to clean energy and energy efficiency and investment property in the UK.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Sigma Capital Group invests in
Stages Sigma Capital Group invests in
Countries Sigma Capital Group invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 9 contacts → | |||
Investment Focus
Industry
- Software 2 (33%)
- Blockchain 2 (33%)
- Information Technology 2 (33%)
- Energy 1 (17%)
- Gaming 1 (17%)
Stage
- Seed 2 (33%)
- Funding Round 2 (33%)
- Series A 1 (17%)
- Series B 1 (17%)
Country
- United States 2 (33%)
- United Kingdom 2 (33%)
- France 1 (17%)
- Singapore 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alison Martin
Personal Assistant/Office Manager
|
Personal Assistant/Office Manager | Total investments: 0 | Find email | |
|
Duncan Sutherland
Regeneration Director
|
Regeneration Director | Total investments: 0 | Find email | |
|
Francesca Ward
Administration Support
|
Administration Support | Total investments: 0 | Find email | |
|
Graham Barnet
Chief Executive Officer
|
Chief Executive Officer | Total investments: 0 | Find email | |
|
Jay Barnet
Associate
|
Associate | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
OpenEden is a financial system that helps bring real-world assets on-chain to unlock value. | Seed / Dec 01, 2025 | |
|
|
Metaverse Game Studios is a leading blockchain game development studio. | $10M / Seed / Mar 14, 2022 | |
|
|
IRT Surveys is specialises in rapid analysis and quantification of infrared images to help identify energy inefficiencies and property defects, enabling you to plan for the future.With a consistent focus on innovation, our thermal imaging services have been complemented by our proprietary software, which enables images to be quantified for energyloss. | $524K / Series A / Apr 17, 2009 | |
|
|
Exterity has been delivering enterprise-class building IPTV solutions since 2001, and today its products are used in 29 countries by more than 1000 customers, including some of the world's largest corporations. Exterity products enable organizations to distribute broadcast-quality digital TV and video over building or campus IP networks(LANs) to a virtually unlimited number of users, with centralized management, configuration, and control. | $1.4M / Dec 19, 2008 | |
|
|
Founded in 2003 by Graeme Bryce and Dave Reynolds, Factonomy licenses its technology framework to companies to help them reduce the time and cost it takes to develop applications. Factonomy's agile software environment enables the rapid development of web-enabled business applications using declarative XML only. Unlike other developmentplatforms, the Factonomy Framework allows developers to work independently on functionality, content and style, providing a coherent end-to-end environment so they can deliver solutions which are flexible and cost effective. | $1.7M / Series B / May 30, 2008 | |
|
|
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. The company applies its pioneering expertise in hypoxia-inducible factor (HIF), connective tissuegrowth factor (CTGF) biology, and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer.FibroGen's product Roxadustat is an oral small-molecule inhibitor of HIF prolyl hydroxylase activity in worldwide Phase 3 clinical development for the treatment of anemia in chronic kidney disease (CKD), with a New Drug Application currently under review in China by the State Drug Administration or SDA (formerly the China Food and Drug Administration). | $100M / Feb 17, 2005 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sigma Capital Group invest in?
Sigma Capital Group invests primarily in Software, Blockchain and Information Technology startups, most often at Seed and Funding Round stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Sigma Capital Group?
Public channels for Sigma Capital Group include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sigma Capital Group?
The team at Sigma Capital Group includes Alison Martin (Personal Assistant/Office Manager), Duncan Sutherland (Regeneration Director) and Francesca Ward (Administration Support), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!